Inhibition of cyclic nucleotide phosphodiesterase activity by an endogenous factor
- PMID: 177458
Inhibition of cyclic nucleotide phosphodiesterase activity by an endogenous factor
Abstract
Cyclic nucleotide phosphodiesterase activity of several tissues of rat is inhibited by an endogenous factor isolated from rat adipocytes following exposure of these cells to agents that raise intracellular cyclic AMP levels. The inhibitory action was demonstrated with varying cAMP concentrations from 0.1-400 muM. Enzyme from 10,000 X g supernatant of epididymal adipose tissue was inhibited approximately 2-3 fold more than the plasma membrane of adipocytes by a given concentration of the feedback regulator. Kinetic analysis of cAMP phosphodiesterase of plasma membrane showed that feedback regulator (8.8 U/ml) inhibited the Vmax 48%. The maximum inhibition of phosphodiesterase by feedback regulator (20 U/ml) was about 80%. The apparent Km for cAMP was increased. The ability of phosphodiesterase from several tissues of rat (10,000 X g supernatant) to hydrolyze cAMP and cGMP was tested. Feedback regulator inhibited cGMP hydrolysis in cardiac muscle and 5 other tissues 23-92% more than it inhibited the hydrolysis of cAMP. The physiological significance of this inhibitory effect can begin to be clarified when the feedback regulator is purified to homogeneity and characterized.
Similar articles
-
Alterations in cyclic AMP phosphodiesterase activities during differentiation of 3T3-L1 cells.J Cyclic Nucleotide Protein Phosphor Res. 1983;9(2):143-54. J Cyclic Nucleotide Protein Phosphor Res. 1983. PMID: 6196386
-
Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.Mol Pharmacol. 1990 Feb;37(2):206-14. Mol Pharmacol. 1990. PMID: 2154670
-
Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.Mol Pharmacol. 1993 Nov;44(5):1027-35. Mol Pharmacol. 1993. PMID: 8246905
-
Tissue and species specificity of cardiac cAMP-phosphodiesterase inhibitors.Adv Second Messenger Phosphoprotein Res. 1992;25:307-20. Adv Second Messenger Phosphoprotein Res. 1992. PMID: 1313264 Review. No abstract available.
-
Subcellular localization and biological function of specific cyclic nucleotide phosphodiesterases.J Mol Cell Cardiol. 1987 Oct;19(10):1037-40. doi: 10.1016/s0022-2828(87)80575-8. J Mol Cell Cardiol. 1987. PMID: 2830403 Review. No abstract available.
Cited by
-
Cellular levels of feedback regulator of adenylate cyclase and the effect of epinephrine and insulin.Proc Natl Acad Sci U S A. 1975 Dec;72(12):4739-43. doi: 10.1073/pnas.72.12.4739. Proc Natl Acad Sci U S A. 1975. PMID: 174073 Free PMC article.
-
Hydrophobic interaction of soluble 3':5' cyclic nucleotide phosphodiesterase with octyl-sepharose.Mol Cell Biochem. 1980 May 7;30(3):157-64. doi: 10.1007/BF00230169. Mol Cell Biochem. 1980. PMID: 6250021 No abstract available.
-
Epinephrine-induced elevation of guanosine 3':5'-cyclic monophosphate in isolated fat cells of rat.Proc Natl Acad Sci U S A. 1978 Jun;75(6):2684-8. doi: 10.1073/pnas.75.6.2684. Proc Natl Acad Sci U S A. 1978. PMID: 208070 Free PMC article.